找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Estrogen Receptor and Breast Cancer; Celebrating the 60th Xiaoting Zhang Book 2019 Springer Nature Switzerland AG 2019 estrogen receptor.br

[復制鏈接]
樓主: infection
21#
發(fā)表于 2025-3-25 05:33:56 | 只看該作者
Cultural Understanding of Soilsen receptor activities to determine and evaluate the physiological responses, in reproductive/gonadal tissues, neuroendocrine actions, and obesity related to adipose tissue and bone as some examples, linked to that receptors’ functional domains and tissue specificity.
22#
發(fā)表于 2025-3-25 11:22:14 | 只看該作者
23#
發(fā)表于 2025-3-25 13:12:05 | 只看該作者
Ethnicity (Not Race) and Belonging, the context of ligand specificity and antiestrogen therapies. Here, we review the cross talk between ERα and miRNAs and their involvement in breast cancer progression, as well as resistance to endocrine therapy. We also briefly discuss the interaction of miRNAs with estrogen-related receptors (ERRs) and ERβ in mediating breast tumorigenesis.
24#
發(fā)表于 2025-3-25 16:35:23 | 只看該作者
25#
發(fā)表于 2025-3-25 22:30:51 | 只看該作者
Cultural and Creative Industries with a safe SERM but to prevent breast cancer at the same time. Raloxifene is the result with no increase in endometrial cancer incidence. There are now five FDA-approved SERMS available for use: tamoxifen, raloxifene, bazedoxifene, toremifene, and ospemifene. All have connections with discovery and basic research in Jordan’s laboratory.
26#
發(fā)表于 2025-3-26 04:03:01 | 只看該作者
27#
發(fā)表于 2025-3-26 07:48:34 | 只看該作者
Physiological and Pathological Roles of Estrogen Receptor,en receptor activities to determine and evaluate the physiological responses, in reproductive/gonadal tissues, neuroendocrine actions, and obesity related to adipose tissue and bone as some examples, linked to that receptors’ functional domains and tissue specificity.
28#
發(fā)表于 2025-3-26 10:13:41 | 只看該作者
29#
發(fā)表于 2025-3-26 15:58:44 | 只看該作者
Estrogen Receptor Regulation of MicroRNAs in Breast Cancer, the context of ligand specificity and antiestrogen therapies. Here, we review the cross talk between ERα and miRNAs and their involvement in breast cancer progression, as well as resistance to endocrine therapy. We also briefly discuss the interaction of miRNAs with estrogen-related receptors (ERRs) and ERβ in mediating breast tumorigenesis.
30#
發(fā)表于 2025-3-26 17:58:04 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 09:46
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
田东县| 苍南县| 裕民县| 苍山县| 大埔区| 贵德县| 讷河市| 天镇县| 宁晋县| 绵阳市| 三亚市| 嘉荫县| 静安区| 乐东| 东海县| 沿河| 青海省| 崇阳县| 乐东| 黔南| 乌鲁木齐县| 东乡族自治县| 涡阳县| 孝义市| 留坝县| 通城县| 黑水县| 平利县| 万年县| 卓尼县| 江都市| 岫岩| 丰都县| 马龙县| 磐石市| 新津县| 威宁| 甘肃省| 滁州市| 抚顺县| 甘孜县|